首页> 外文期刊>Cell death and differentiation >Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1
【24h】

Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1

机译:视网膜母细胞瘤肿瘤抑制蛋白的磷酸化和失活取决于与Pin1的直接相互作用

获取原文
获取原文并翻译 | 示例
           

摘要

Inactivation of the retinoblastoma protein (pRb) by phosphorylation triggers uncontrolled cell proliferation. Accordingly, activation of cyclin-dependent kinase (CDK)/cyclin complexes or downregulation of CDK inhibitors appears as a common event in human cancer. Here we show that Pin1 (protein interacting with NIMA (never in mitosis A)-1), a peptidylprolyl isomerase involved in the control of protein phosphorylation, is an essential mediator for inactivation of the pRb. Our results indicate that Pin1 controls cell proliferation by altering pRb phosphorylation without affecting CDK and protein phosphatase 1 and 2 activity. We demonstrated that Pin1 regulates tumor cell proliferation through direct interaction with the spacer domain of the pRb protein, and allows the interaction between CDK/cyclin complexes and pRb in mid/late G1. Phosphorylation of pRb Ser 608/612 is the crucial motif for Pin1 binding. We propose that Pin1 selectively boosts the switch from hypo-to hyper-phosphorylation of pRb in tumor cells. In addition, we demonstrate that the CDK pathway is responsible for the interaction of Pin1 and pRb. Prospectively, our findings therefore suggest that the synergism among CDK and Pin1 inhibitors holds great promise for targeted pharmacological treatment of cancer patients, with the possibility of reaching high effectiveness at tolerated doses.
机译:视网膜母细胞瘤蛋白(pRb)的失活通过磷酸化触发不受控制的细胞增殖。因此,细胞周期蛋白依赖性激酶(CDK)/细胞周期蛋白复合物的激活或CDK抑制剂的下调似乎是人类癌症中的常见事件。在这里,我们显示Pin1(与NIMA相互作用的蛋白质(在有丝分裂A中从未发生过)-1)是参与蛋白质磷酸化控制的肽基脯氨酰异构酶,是pRb失活的重要介体。我们的结果表明,Pin1通过改变pRb磷酸化而不影响CDK和蛋白磷酸酶1和2的活性来控制细胞增殖。我们证明,Pin1通过与pRb蛋白的间隔域直接相互作用来调节肿瘤细胞增殖,并允许CDK /细胞周期蛋白复合物与pRb在中晚期G1中相互作用。 pRb Ser 608/612的磷酸化是Pin1结合的关键主题。我们提出,Pin1选择性地促进肿瘤细胞中pRb从低磷酸化到超磷酸化的转换。此外,我们证明了CDK通路负责Pin1和pRb的相互作用。因此,前瞻性地,我们的发现因此表明CDK和Pin1抑制剂之间的协同作用对于癌症患者的靶向药物治疗具有广阔的前景,并有可能在耐受剂量下达到很高的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号